Study of Recombinant Human Endostatin Combined With Temozolomide and Irinotecan in Recurrent Gliomas
Condition(s):Glioblastoma, Recurrent; Lower Grade Glioma, RecurrentLast Updated:April 19, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Glioblastoma, Recurrent; Lower Grade Glioma, RecurrentLast Updated:April 19, 2023Recruiting
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:February 11, 2013Completed
Condition(s):NSCLC; Solid TumorLast Updated:June 2, 2020Unknown status
Condition(s):Nasopharyngeal CarcinomaLast Updated:February 19, 2014Unknown status
Condition(s):Colorectal NeoplasmLast Updated:March 8, 2011Unknown status
Condition(s):Non-small Cell Lung CancerLast Updated:October 17, 2012Unknown status
Condition(s):Radiation Pneumonitis; EndostatinLast Updated:February 23, 2024Completed
Condition(s):Head and Neck NeoplasmsLast Updated:November 5, 2014Unknown status
Condition(s):Solid TumorsLast Updated:December 28, 2007Terminated
Condition(s):Non-Small-Cell Lung CancerLast Updated:October 12, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.